Here we go again. Textile companies that spent money on retooling to make masks and hospital gowns now losing to China dumping PPE in the U.S.
Worried about climate change, Senator Wyden and the Democrats want to give cleantech and energy companies permanent tax breaks. He faces some serious opposition.
McKinsey has turned the corner on the Asia-centric model of globalization. It’s a “now-or-never” moment for US manufacturing. Here’s where CPA sees eye-to-eye.
How do we bring back generic drug manufacturing to the United States in order to be less reliant on India, China? A National Academies of Science conference brings in some experts to try and answer that, including the chair of CPA Healthcare Committee.
Recent shortages an example of America’s over-bearing dependence on Chinese supply chains. The time is now to take action to reverses this decades-long headwind to U.S. manufacturing and its labor force.
A Senate hearing today looked back at our early response to the pandemic. A year later, what went right, what went wrong, and how to re-shore pharma now.
Lawyers from Wiley are telling their clients to prepare for ongoing supply disruptions due to Biden’s China policies.
It’s time for Elizabeth Warren to re-introduce her pharmaceutical supply chain legislation.
A new bill in the Senate seeks to prevent China solar imports, especially for publicly funded solar installations.
Biden releases 10-year $2 trillion infrastructure spending plan. Here’s what’s inside.
